Research Centre

Go back to current news

March 09 , 2018

CADTH has amended their common drug review process, accepting submissions up to six months (previously three months) before notice of compliance (NOC) is issued by Health Canada.

The change is expected to reduce the time between Health Canada regulatory approval and CADTH's reimbursement recommendations for prescription drugs in Canada.

Access further information

Search Research
News Archives

Name or keyword: 7